SQM heads into its August 18 report having already told investors the story Wall Street wants to hear: lithium prices have roughly doubled since the start of the fiscal year, a new joint venture with Codelco is generating meaningful cash for the Chilean state, and management has raised volume guidance twice in a row. The question now is whether the numbers can keep pace with a narrative that has become almost aggressively optimistic.

Consensus calls for EPS of $2.03 on revenue of $2.38 billion, which would represent year-over-year growth of roughly 555% and 128%, respectively. Those figures look staggering, but they mostly reflect how depressed last year's base was, when lithium prices sat near $4-5 per kilogram. The more relevant comparison is sequential. Last quarter SQM posted $1.28 in EPS on $1.76 billion in revenue, with realized lithium prices around $18 per kilogram, up sharply from about $10 the quarter before. Management guided for prices to move even higher into this quarter, so the real test isn't whether SQM grows year-over-year, it's whether pricing momentum actually continued as promised.

That distinction matters because SQM's story over the past four quarters has been one of escalating confidence. Each call brought another guidance raise, first on lithium volumes, then on potassium nitrate (SPN), then on both simultaneously last quarter. Lithium volume guidance moved from roughly 10% growth to 15%, Chile production targets rose above 270,000 tons, and SPN guidance jumped from low single digits to around 10% after China suspended potassium nitrate exports in late March, handing SQM a share-gain opportunity. Iodine demand also stayed firm, with spot prices rising in Asia. This quarter needs to show those trends actually materialized rather than simply being management's optimistic framing. Did lithium volumes come in near the raised 15% growth target? Did SPN pricing and share gains show up in the numbers now that China's export gap has had a full quarter to play out? Iodine cost inflation from the Maria Elena ramp-up and war-related fuel costs is also worth watching, since that was one of the few soft spots in an otherwise upbeat call.

Investors haven't fully bought into the story yet. Shares are down 7.5% since the last report, badly lagging the S&P 500's 3.6% gain over the same stretch, a gap of more than 11 percentage points. That's a notable disconnect given how strongly the previous call was received, and it suggests the market remains skeptical about how durable this pricing surge really is, or is bracing for lithium price volatility that management itself flagged as difficult to predict beyond the current quarter. Sentiment has ticked up modestly heading into this report, from essentially flat to a mildly bullish +0.096, but that's a far cry from euphoria.

Technically, the stock sits just below its 200-day moving average of $73.68, trading in a range between $65.45 and $87.52 since the last report, a considerably wider band than the prior quarter's $65 to $98 range compressed toward the lower half. That positioning suggests the market is waiting for confirmation rather than anticipating another blowout.

The central issue is straightforward. SQM has raised the bar for itself twice in a row, and now needs volumes, pricing and margins to validate that confidence rather than merely repeat it. A report that shows lithium pricing holding near guided levels, SPN gains materializing from the China export vacuum, and iodine costs stabilizing would confirm the acceleration story. Anything short of that, particularly signs that lithium pricing is already rolling over or that the promised SPN share gains haven't shown up, would give skeptics more reason to question whether this rebound has staying power or was simply a one-quarter pricing spike.